1. 1. Natoli S, Fontana C, Favaro M, et al. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. BMC Infect Dis. 2009;9:83.
2. 2. Tacconelli E, Tumbarello M, Donati KG, et al. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin Infect Dis. 2001;33:1628-35.
3. 3. Biavasco F, Vignaroli C, Varaldo PE. Glycopeptide resistance in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis. 2000;19:403-17.
4. 4. Sloos JH, van de Klundert JA, Dijkshoorn L, et al. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. J Antimicrob Chemother.1998;42:787-91.
5. 5. Tsakris A, Papadimitriou E, Douboyas J, et al. Emergence of teicoplanin-resistant Staphylococcus haemolyticus clinical isolates in Greece. J Antimicrob Chemother. 2000;46:1040-1.